Clinical Trial Update: Efficacy and Safety of Peginterferon Alfa-2b and Ribavirin Therapy in Subjects With Type C Compensated Liver Cirrhosis (Study P05116) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of peginterferon alfa-2b plus ribavirin in subjects with Hepatitis C and compensated liver cirrhosis; results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Liver Cirrhosis

Drugs mentioned

• Peginterferon alfa-2b (Peginterferon alfa-2b)
• Ribavirin (ribavirin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic, Liver Cirrhosis | Phase 3 | Status: COMPLETED | Results posted: 2011-12-02